Joel Becker
Chief Executive Officer bij NEUROPACE, INC.
Vermogen: 692 604 $ op 31-03-2024
Profiel
Joel D.
Becker is currently the Chief Executive Officer & Director at NeuroPace, Inc. He previously worked as the Chief Executive Officer at Xchangelabs LLC from 2017 to 2018, President-Americas Division at St. Jude Medical LLC from 2014 to 2016, President-CRM & Neuromodulation at Integer Holdings Corp.
from 2019 to 2022, and President at Viking North Ventures LLC from 2016 to 2019.
Becker received his undergraduate degree from Augustana College (Illinois) and his MBA from The Curtis L.
Carlson School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NEUROPACE, INC.
0.19% | 27-02-2024 | 52 470 ( 0.19% ) | 692 604 $ | 31-03-2024 |
Actieve functies van Joel Becker
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUROPACE, INC. | Chief Executive Officer | 10-07-2023 |
Eerdere bekende functies van Joel Becker
| Bedrijven | Functie | Einde |
|---|---|---|
| INTEGER HOLDINGS CORPORATION | Corporate Officer/Principal | 07-10-2022 |
| Viking North Ventures LLC | President | 01-04-2019 |
| Xchangelabs LLC | Chief Executive Officer | 01-08-2018 |
| ST JUDE MEDICAL INC | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Joel Becker
| Augustana College (Illinois) | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INTEGER HOLDINGS CORPORATION | Health Technology |
| NEUROPACE, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
St. Jude Medical LLC
 St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
| Viking North Ventures LLC | |
| Xchangelabs LLC |
